Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 15

1.

Combined PET/MRI: one step further in multimodality imaging.

Sauter AW, Wehrl HF, Kolb A, Judenhofer MS, Pichler BJ.

Trends Mol Med. 2010 Nov;16(11):508-15. doi: 10.1016/j.molmed.2010.08.003. Epub 2010 Sep 28. Review.

PMID:
20851684
2.

Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT.

Boss A, Bisdas S, Kolb A, Hofmann M, Ernemann U, Claussen CD, Pfannenberg C, Pichler BJ, Reimold M, Stegger L.

J Nucl Med. 2010 Aug;51(8):1198-205. doi: 10.2967/jnumed.110.074773. Epub 2010 Jul 21.

3.

FDG PET/CT in oncology: "raising the bar".

Patel CN, Goldstone AR, Chowdhury FU, Scarsbrook AF.

Clin Radiol. 2010 Jul;65(7):522-35. doi: 10.1016/j.crad.2010.01.003. Epub 2010 Mar 4.

PMID:
20541652
4.

The medicinal chemistry of theragnostics, multimodality imaging and applications of nanotechnology in cancer.

Majumdar D, Peng XH, Shin DM.

Curr Top Med Chem. 2010;10(12):1211-26. Review.

PMID:
20388107
5.

[18F]FDG PET/CT imaging of colorectal cancer: a pictorial review.

Chowdhury FU, Shah N, Scarsbrook AF, Bradley KM.

Postgrad Med J. 2010 Mar;86(1013):174-82. doi: 10.1136/pgmj.2009.079087. Review.

PMID:
20237012
6.

Multimodality imaging probes: design and challenges.

Louie A.

Chem Rev. 2010 May 12;110(5):3146-95. doi: 10.1021/cr9003538. Review. No abstract available.

7.

Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging.

Nam T, Park S, Lee SY, Park K, Choi K, Song IC, Han MH, Leary JJ, Yuk SA, Kwon IC, Kim K, Jeong SY.

Bioconjug Chem. 2010 Apr 21;21(4):578-82. doi: 10.1021/bc900408z.

PMID:
20201550
8.

PET/MRI: paving the way for the next generation of clinical multimodality imaging applications.

Pichler BJ, Kolb A, Nägele T, Schlemmer HP.

J Nucl Med. 2010 Mar;51(3):333-6. doi: 10.2967/jnumed.109.061853. Epub 2010 Feb 11.

9.

Multimodality imaging: beyond PET/CT and SPECT/CT.

Cherry SR.

Semin Nucl Med. 2009 Sep;39(5):348-53. doi: 10.1053/j.semnuclmed.2009.03.001. Review.

10.

Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions.

Delbeke D, Schöder H, Martin WH, Wahl RL.

Semin Nucl Med. 2009 Sep;39(5):308-40. doi: 10.1053/j.semnuclmed.2009.03.002. Review.

PMID:
19646557
11.

'Two is better than one'--probes for dual-modality molecular imaging.

Jennings LE, Long NJ.

Chem Commun (Camb). 2009 Jun 28;(24):3511-24. doi: 10.1039/b821903f. Epub 2009 May 5. Review.

PMID:
19521594
12.

Dual-modality probes for in vivo molecular imaging.

Lee S, Chen X.

Mol Imaging. 2009 Mar-Apr;8(2):87-100. Review.

PMID:
19397854
13.

Pre-clinical PET/MR: technological advances and new perspectives in biomedical research.

Wehrl HF, Judenhofer MS, Wiehr S, Pichler BJ.

Eur J Nucl Med Mol Imaging. 2009 Mar;36 Suppl 1:S56-68. doi: 10.1007/s00259-009-1078-0. Review.

PMID:
19194703
14.

Multimodality in vivo imaging systems: twice the power or double the trouble?

Cherry SR.

Annu Rev Biomed Eng. 2006;8:35-62. Review.

PMID:
16834551
15.

The contribution of PET/CT to improved patient management.

Ell PJ.

Br J Radiol. 2006 Jan;79(937):32-6. Review.

PMID:
16421402

Supplemental Content

Support Center